Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sunshine Biopharma Inc.SBFM · Entity 8329 | Director · Chief Operating Officer | January 06, 2021 | February 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sunshine Biopharma Inc.
Report date January 06, 2021 · Filed February 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,342,500 |
Reported balance
After 2021-01-06 transaction · row 1
1 source rowRow 1 · 2021-01-06 · Grant · Acquired 20,000,000 · Balance 23,342,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2021 Filed Feb 16, 2021 17:36 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 20,000,000 | $0.00 | $20,000.00 |
DisclosureSEC source: 0001128732-21-000003 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,342,500 Read SEC document |
| December 19, 2019 Filed Jul 13, 2020 18:39 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 1,300,000 | $0.00 | $1,300.00 |
DisclosureSEC source: 0001128732-20-000004 · primary_doc.xml · nonDerivative · entry 2 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,342,500 F1 · shares: The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person. F1 · balance_after: The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person. Read SEC document |
| October 20, 2019 Filed Jul 13, 2020 18:39 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 1,100,000 | $0.00 | $1,100.00 |
DisclosureSEC source: 0001128732-20-000004 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,042,500 F1 · shares: The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person. F1 · balance_after: The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person. Read SEC document |
| September 02, 2019 Filed Oct 7, 2019 13:19 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 13,000,000 | $0.00 | $13,000.00 |
DisclosureSEC source: 0001128732-19-000032 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850,000 F1 · balance_after: Issuer effectuated a reverse stock split effective February 1, 2019 wherein one share of Common Stock of the Issuer was issued for each 20 shares of Common Stock issued and oustanding resulting in Reporting Person owning 5,850,000 shares of Common Stock of the Issuer as of that date. Read SEC document |
| August 27, 2018 Filed Sep 14, 2018 14:23 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 38,000,000 | $0.00 | $38,000.00 |
DisclosureSEC source: 0001128732-18-000013 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,467,000 Read SEC document |
| August 27, 2018 Filed Oct 7, 2019 13:04 UTC Amendment | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 38,000,000 | $0.00 | $38,000.00 |
DisclosureSEC source: 0001128732-19-000031 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000,000 Read SEC document |
| June 20, 2018 Filed Jun 28, 2018 21:57 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 27,000,000 | $0.00 | $27,000.00 |
DisclosureSEC source: 0001128732-18-000008 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,467,000 Read SEC document |
| June 20, 2018 Filed Oct 7, 2019 12:55 UTC Amendment | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 27,000,000 | $0.00 | $27,000.00 |
DisclosureSEC source: 0001128732-19-000030 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,000,000 Read SEC document |
| April 22, 2018 Filed Oct 4, 2019 15:57 UTC Amendment | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 12,000,000 | $0.00 | $12,000.00 |
DisclosureSEC source: 0001128732-19-000027 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000,000 Read SEC document |
| July 20, 2017 Filed Sep 8, 2017 13:55 UTC | Sunshine Biopharma Inc. SFBM · Entity 8329 | GrantCommon Stock | 14,000,000 | $0.00 | $14,000.00 |
DisclosureSEC source: 0001128732-17-000033 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,467,000 Read SEC document |
| July 20, 2017 Filed Oct 4, 2019 23:10 UTC Amendment | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 14,000,000 | $0.00 | $14,000.00 |
DisclosureSEC source: 0001128732-19-000029 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000,000 Read SEC document |
| December 06, 2016 Filed Dec 16, 2016 00:58 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 26,000,000 | $0.00 | $26,000.00 |
DisclosureSEC source: 0001128732-16-000038 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,467,000 Read SEC document |
| December 06, 2016 Filed Oct 4, 2019 23:03 UTC Amendment | Sunshine Biopharma Inc. SBFM · Entity 8329 | GrantCommon Stock | 28,000,000 | $0.00 | $28,000.00 |
DisclosureSEC source: 0001128732-19-000028 · primary_doc.xml · nonDerivative · entry 1 MERZOUKI ABDERRAZZAK · CIK 0001636418 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.